In a message dated 7/27/00 6:48:01 AM EST, [email protected] writes: << Subj: Re: CS and colds Date: 7/27/00 6:48:01 AM EST From: [email protected] (Ivan Anderson) Reply-to: [email protected] To: [email protected] Roger, You would also need to take into account the silver distribution throughout the body before assigning a tissue concentration.
Ivan: How would you go about doing this? The distribution will not be even, indeed probably 90%+ will be found in the liver and kidneys after a short time. Ivan: Could you briefly explain how the body accomplishes this? The initial high excretion rate via the kidneys could well be indicative of low numbers of metal scavenging enzymes, which increase in number in the face of increased metal concentrations and move the metal load to the liver and from there to the faeces. Ivan: Again, a brief elaboration would help me understand what you are saying. In terms of systemic protection, the silver ions must be able to react with the pathogen, which means they must be free or bound less securely to the tissue than they would be to pathogenic cells which happen along. Ivan: Are you saying that systemic protection is difficult to achieve because residual CS is bound too tightly to cells ? I believe the best systemic protection will be found in a little often. Ivan: How much (in mg.) and how often? Please take your time in answering these questions. I know you've got a lot on your plate, but anything you can add to your original comments would help me get a better grasp of how the body interacts with CS in general, and how best to use CS systemically. Thanks, Roger -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: [email protected] -or- [email protected] with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: [email protected] Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <[email protected]>
